Found 50 results
Author [ Title(Desc)] Type Year
Filters: Author is Lindblad, R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
B. Tai, Hu, L., Ghitza, U. E., Sparenborg, S., Van Veldhuisen, P., and Lindblad, R., Patient Registries for Substance Use Disorders, Subst Abuse Rehabil, vol. 5, pp. 81-86, 2014.
R. A. Wood, Stablein, D., Henning, A. K., Lindblad, R., and Sicherer, S. H., A Phase 1 Study of Heat/Phenol Killed, E. coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy, in AAAAI - American Academy of Allergy, Asthma & Immunology, Orlando, FL, 2012, vol. 129(2), p. AB27.
R. A. Wood, Sicherer, S. H., Burks, A. W., Grishin, A., Henning, A. K., Lindblad, R., Stablein, D., and Sampson, H. A., A Phase 1 Study of Heat/Phenol-Killed, E. coli - Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy, Allergy, vol. 68, pp. 803-808, 2013.
R. A. Wood, Sicherer, S. H., Burks, A. W., Grishin, A., Henning, A. K., Lindblad, R., Stablein, D., and Sampson, H. A., A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy., Allergy, vol. 68, no. 6, pp. 803-8, 2013.
W. Reed, Noga, S., Gee, A., Rooney, C., Wagner, J., McCullough, J., McKenna, D., Whiteside, T., Donnenberg, A., Baker, A., Lindblad, R., Wagner, E., and Mondoro, T., Production Assistance for Cellular Therapies (PACT): Four-Year Experience from the United States National Heart, Lung, and Blood Institute (NHLBI) Contract Research Program in Cell and Tissue Therapies, Transfusion, vol. 49, pp. 786-796, 2009.
S
T. Whiteside, Griffin, D., Stanson, J., Gooding, W., McKenna, D., Sumstad, D., Kadidlo, D., Gee, A., Durett, A., Lindblad, R., Wood, D., and Styers, D., Shipping of Therapeutic Somatic Cell Products, Cytotherapy, vol. 13, pp. 201-213, 2011.
J. R. T. Lakey, Ricordi, C., Hering, B., DiMercurio, B., Lindblad, R., Olack, B., Reems, J. A., Ansite, J., Brandhorst, H., Bertuzzi, F., Berney, T., Vivano, L., O’Neil, J., Close, N., and Shapiro, A. M. J., Standardization of Human Islet Isolation for a Multi-Center Transplant Trial, 2004.
D. M. Fleischer, Burks, A. W., Vickery, B. P., Scurlock, A. M., Wood, R. A., Jones, S. M., Sicherer, S. H., Liu, A. H., Stablein, D., Henning, A. K., Mayer, L., Lindblad, R., Plaut, M., and Sampson, H. A., Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial, J Allergy Clin Immunol, vol. 131, pp. 119-127.e1-7, 2013.
D. M. Fleischer, Wood, R. A., Jones, S. M., Sicherer, S. H., Liu, A. H., Stablein, D., Henning, A., Mayer, L., Lindblad, R., and Sampson, H. A., Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial, in AAAAI - American Academy of Allergy, Asthma & Immunology, 2012, vol. 129(2), p. AB66.
A. W. Burks, Wood, R. A., Jones, S. M., Sicherer, S. H., Fleischer, D. M., Scurlock, A. M., Vickery, B. P., Liu, A. H., Henning, A. K., Lindblad, R., Dawson, P., Plaut, M., Sampson, H. A., and CoFAR), T. Consortium, Sublingual Immunotherapy for Peanut Allergy: Long-Term Follow-up of a Randomized Multicenter Trial, J Allergy Clin Immunol, 2015.
R. Lindblad, Quinnan, K., and Wood, D., A Successful Support Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group, Transfusion, vol. 53, p. Supplement AP34, 2013.
R. Lindblad, Styers, D., and Wood, D., A Successful Web Seminar Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group, in AABB Annual Meeting & TXPO, Denver, CO, Denver, CO, 2013, No. 2S., vol. 53, p. Supplement AP40.